COMMUNIQUÉS West-GlobeNewswire

-
argenx reports second quarter business update and half-year 2018 financial results
02/08/2018 -
BioCryst Pharmaceuticals Prices Public Offering of Common Stock
02/08/2018 -
Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange
02/08/2018 -
La Jolla Pharmaceutical Company to Release Second Quarter 2018 Financial Results and Host a Webcasted Conference Call on August 8, 2018
01/08/2018 -
FibroGen to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
01/08/2018 -
Intuitive Appoints Don Kania, Ph.D. to its Board of Directors
01/08/2018 -
Denali Therapeutics Announces Positive Clinical Results From LRRK2 Inhibitor Program for Parkinson’s Disease
01/08/2018 -
MyoKardia to Report Second Quarter 2018 Financial Results on Wednesday, August 8, 2018
01/08/2018 -
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/08/2018 -
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
01/08/2018 -
Conformis Announces the first 3D Total Hip Replacement Surgeries performed at JFK Medical Center in Florida
01/08/2018 -
Zafgen to Present at the Canaccord Genuity 38th Annual Growth Conference
01/08/2018 -
Globus Medical Reports Second Quarter 2018 Results
01/08/2018 -
Inovalon Reports Second Quarter 2018 Results
01/08/2018 -
AIT Therapeutics Schedules Fiscal First Quarter 2019 Financial Results Conference Call and Webcast
01/08/2018 -
LeMaitre Vascular to Present at Upcoming Investor Conferences
01/08/2018 -
TRACON to Report Second Quarter 2018 Company Highlights and Financial Results on August 8, 2018
01/08/2018 -
Notification from Oasmia Pharmaceutical AB
01/08/2018 -
Menlo Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
01/08/2018
Pages